Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza (Healthy Volunteers)”

259 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 259 results

Testing effectiveness (Phase 2)Study completedNCT00440362
What this trial is testing

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

Who this might be right for
Influenza
AlphaVax, Inc. 216
Early research (Phase 1)Study completedNCT05426174
What this trial is testing

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 233
Early research (Phase 1)Study completedNCT03330899
What this trial is testing

Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil

Who this might be right for
InfluenzaH7N9 Influenza
Butantan Institute 432
Early research (Phase 1)Study completedNCT00995982
What this trial is testing

VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years

Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT02468115
What this trial is testing

Influenza Challenge Study of VIS410 in Healthy Volunteers

Who this might be right for
Influenza
Visterra, Inc. 46
Large-scale testing (Phase 3)Study completedNCT00644059
What this trial is testing

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

Who this might be right for
Influenza, Human
Novartis 4,902
Large-scale testing (Phase 3)Active Not RecruitingNCT07365826
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 1,390
Not applicableActive Not RecruitingNCT05190432
What this trial is testing

Taxifolin/ergothioneine and Immune Biomarkers in Healthy Volunteers (TaxEr)

Who this might be right for
Antioxidative StressColdInfluenza+2 more
University of Southampton 90
Early research (Phase 1)Study completedNCT02148328
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
Crucell Holland BV 240
Testing effectiveness (Phase 2)Study completedNCT02918006
What this trial is testing

Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Who this might be right for
Influenza
Vaxart 179
Testing effectiveness (Phase 2)Study completedNCT01578317
What this trial is testing

Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 43
Testing effectiveness (Phase 2)Study completedNCT01938352
What this trial is testing

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Who this might be right for
Influenza
Crucell Holland BV 22
Early research (Phase 1)Study completedNCT02888327
What this trial is testing

A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872

Who this might be right for
Influenza in Humans
Alios Biopharma Inc. 68
Not applicableStudy completedNCT00995527
What this trial is testing

Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine

Who this might be right for
Healthy Volunteers
National Heart, Lung, and Blood Institute (NHLBI) 26
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Large-scale testing (Phase 3)Study completedNCT00453986
What this trial is testing

Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,352
Early research (Phase 1)Study completedNCT01990846
What this trial is testing

Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects

Who this might be right for
Influenza
Autoimmune Technologies, LLC 68
Early research (Phase 1)Study completedNCT01656356
What this trial is testing

Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers

Who this might be right for
Preventive Avian Flu
Mahidol University
Early research (Phase 1)UnknownNCT01026350
What this trial is testing

Safety and Efficacy of Oral Colostrum Derived Anti Influenza Antibodies in Healthy Volunteers

Who this might be right for
Influenza
Hadassah Medical Organization 10
Early research (Phase 1)Study completedNCT03345043
What this trial is testing

Safety, Tolerability, and Immunogenicity of VAL-339851 in Healthy Adult Subjects

Who this might be right for
Influenza
ModernaTX, Inc. 156
Load More Results